Utama › Kebimbangan › Missouri
Kajian klinikal Kebimbangan di Missouri
7 kajian untuk Kebimbangan sedang mencari peserta di lokasi di Missouri.
Bandar di Missouri
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, St Louis
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07065240Efficacy of a Multi-level School Intervention for LGBTQ Youth
- Washington University in St. Louis, St Louis
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 12 hingga 20 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05541406Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
- Children's Mercy, Kansas City
Mengambil peserta
Umur 13 hingga 17 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07607730Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT06162741Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
- Washington University School of Medicine, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07673380Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
- Washington University in St. Louis School of Medicine, St Louis
Mengambil peserta
Umur 45 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06978166INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
- Washington University School of Medicine, St Louis
Mengambil peserta
Umur 60 ke atas · Semua jantina · Dikemas kini 25 Mac 2026 · NCT07283783Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.